In various cancers, including renal cell carcinoma, melanoma, and breast, gastric, ovarian, and cervical cancers, a decreased CD8+ cell to Treg ratio correlates with poor prognosis [38–40]. This evidence concerns the gene CD8A and cervical cancer.